MIR4447

Across TCGA pan-cancer cohorts, MIR4447 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR4447 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR4447 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4447 expression acts as an unfavorable survival marker.

DLBC, KIRC, and BRCA are the cancer types where MIR4447 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.144	0.800	.003	79	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	36	view →
BRCA	OS	Tertile	III,IV	0.207	0.833	<.001	36	view →
TGCT	DFS	Tertile	All	0.076	0.801	.001	18	view →
LGG	OS	Tertile	All	0.189	0.527	.011	18	view →
UCEC	OS	Tertile	All	0.896	0.926	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR4447–DLBC (OS)

Open the DLBC breakdown →